Bernstein Harold bought MAZE
December 29, 2025 · Form 4 insider transaction
Bernstein Harold bought 45,000 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $468.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$10.42
Total value
$468.9K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 29, 2025
Filing dateDecember 31, 2025
Shares owned after45,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.